More than half of England's poorest citizens risk undetected bowel cancer
12/09/2015
Bowel cancer is the UK's second biggest cause of cancer death, and screening is offered through the National Health Service to everyone from age 60.
Could protein levels help diagnose bipolar disorder?
12/09/2015
Diagnosing mental illness has never been simple. New research plumbs the depths of protein analysis on the hunt for the chemical fingerprints of bipolar disorder.
Rapid molecular assay may help diagnose sepsis
12/08/2015
Measuring the levels of RNA biomarkers in blood may help quickly differentiate sepsis from infection-negative systemic inflammation, according to research published in PLOS Medicine.
Placental cell therapy mitigates bone marrow damage caused by high levels of radiation
12/08/2015
Cell therapy derived from the human placenta may be an effective new means for restoring cell damage caused by high levels of radiation that could occur in the event of a nuclear catastrophe.
First-ever recording of the battle between a tumor cell and an immune cell
12/08/2015
Special microscopy exposes a tumor's weak spot.Metastasizing cancer cells do not destroy tissue, but crawl along the paths that have already been created by blood vessels, nerve bundles and other...
Textbooks on cells should be rewritten
12/08/2015
Ground-breaking new Danish research has shown that the current scientific description of the human cell cycle needs to be revised.
FDA clears military traumatic wound dressing for use in the civilian population
12/08/2015
The U.S. Food and Drug Administration has cleared the use of the XSTAT 30 wound dressing, an expandable, multi-sponge dressing used to control severe, life-threatening bleeding from wounds in areas...
Adaptive Biotechnologies and collaborators from several academic institutions have presented data showing that MRD testing using the company's clonoSEQ® Process at one year post-transplant can...
Adaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T-cell and B-cell receptors of the adaptive immune system, and collaborators...
Common therapy for prostate cancer may raise risk of Alzheimer's
12/08/2015
A study of patient records suggests ADT - a testosterone-lowering therapy - for prostate cancer may raise the risk for Alzheimer's disease and says further research is needed.